Analysts think VIGL stock price could increase by 391%
Sep 07, 2024, 6:26 AM
0.73%
What does VIGL do
Vigil Neuroscience, based in Watertown, Massachusetts, specializes in biotechnology research for neurodegenerative diseases and employs 65 staff. Their lead candidate, VGL101, is in Phase 2 trials for leukoencephalopathy, while VG-3927 targets Alzheimer’s.
10 analysts think VIGL stock price will increase by 391.39%. The current median analyst target is $16.83 compared to a current stock price of $3.42. The lowest analysts target is $4.04 and the highest analyst target is $24.15.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.